IL1B and neoplasm: LMP1-mediated glycolysis enhances the production of IL-1β, IL-6, and GM-CSF, the proliferation of tumor-associated MDSCs, and the inhibition of T-cells and NK cells, which lead to tumor immunosuppression [29, 30].